69 related articles for article (PubMed ID: 15063784)
1. Generation of a panel of antibodies against proteins encoded on human chromosome 21.
Wiseman FK; Sheppard O; Linehan JM; Brandner S; Tybulewicz VL; Fisher EM
J Negat Results Biomed; 2010 Aug; 9():7. PubMed ID: 20727138
[TBL] [Abstract][Full Text] [Related]
2. Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome.
Lana-Elola E; Aoidi R; Llorian M; Gibbins D; Buechsenschuetz C; Bussi C; Flynn H; Gilmore T; Watson-Scales S; Haugsten Hansen M; Hayward D; Song OR; Brault V; Herault Y; Deau E; Meijer L; Snijders AP; Gutierrez MG; Fisher EMC; Tybulewicz VLJ
Sci Transl Med; 2024 Jan; 16(731):eadd6883. PubMed ID: 38266108
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics characterization of a mouse embryonic stem cell model of Down syndrome.
Wang Y; Mulligan C; Denyer G; Delom F; Dagna-Bricarelli F; Tybulewicz VL; Fisher EM; Griffiths WJ; Nizetic D; Groet J
Mol Cell Proteomics; 2009 Apr; 8(4):585-95. PubMed ID: 19001410
[TBL] [Abstract][Full Text] [Related]
4. The sequence of human chromosome 21 and implications for research into Down syndrome.
Gardiner K; Davisson M
Genome Biol; 2000; 1(2):REVIEWS0002. PubMed ID: 11178230
[TBL] [Abstract][Full Text] [Related]
5. Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model.
Waugh KA; Minter R; Baxter J; Chi C; Galbraith MD; Tuttle KD; Eduthan NP; Kinning KT; Andrysik Z; Araya P; Dougherty H; Dunn LN; Ludwig M; Schade KA; Tracy D; Smith KP; Granrath RE; Busquet N; Khanal S; Anderson RD; Cox LL; Estrada BE; Rachubinski AL; Lyford HR; Britton EC; Fantauzzo KA; Orlicky DJ; Matsuda JL; Song K; Cox TC; Sullivan KD; Espinosa JM
Nat Genet; 2023 Jun; 55(6):1034-1047. PubMed ID: 37277650
[TBL] [Abstract][Full Text] [Related]
6. Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes.
Fosu K; Quarshie JT; Sarpong KAN; Aikins AR
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107558
[TBL] [Abstract][Full Text] [Related]
7. Species-specific transcription in mice carrying human chromosome 21.
Wilson MD; Barbosa-Morais NL; Schmidt D; Conboy CM; Vanes L; Tybulewicz VL; Fisher EM; Tavaré S; Odom DT
Science; 2008 Oct; 322(5900):434-8. PubMed ID: 18787134
[TBL] [Abstract][Full Text] [Related]
8. Lung and Heart Biology of the Dp16 Mouse Model of down Syndrome: Implications for Studying Cardiopulmonary Disease.
Colvin KL; Nguyen K; Boncella KL; Goodman DM; Elliott RJ; Harral JW; Bilodeaux J; Smith BJ; Yeager ME
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761959
[TBL] [Abstract][Full Text] [Related]
9. Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling.
Kazuki Y; Uno N; Abe S; Kajitani N; Kazuki K; Yakura Y; Sawada C; Takata S; Sugawara M; Nagashima Y; Okada A; Hiratsuka M; Osaki M; Ferrari G; Tedesco FS; Nishikawa S; Fukumoto K; Takayanagi SI; Kunisato A; Kaneko S; Oshimura M; Tomizuka K
Mol Ther Nucleic Acids; 2021 Mar; 23():629-639. PubMed ID: 33552683
[TBL] [Abstract][Full Text] [Related]
10. Humanized UGT2 and CYP3A transchromosomic rats for improved prediction of human drug metabolism.
Kazuki Y; Kobayashi K; Hirabayashi M; Abe S; Kajitani N; Kazuki K; Takehara S; Takiguchi M; Satoh D; Kuze J; Sakuma T; Kaneko T; Mashimo T; Osamura M; Hashimoto M; Wakatsuki R; Hirashima R; Fujiwara R; Deguchi T; Kurihara A; Tsukazaki Y; Senda N; Yamamoto T; Scheer N; Oshimura M
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3072-3081. PubMed ID: 30718425
[TBL] [Abstract][Full Text] [Related]
11. A novel transchromosomic system: stable maintenance of an engineered Mb-sized human genomic fragment translocated to a mouse chromosome terminal region.
Takehara S; Schulz TC; Abe S; Takiguchi M; Kazuki K; Kishigami S; Wakayama T; Tomizuka K; Oshimura M; Kazuki Y
Transgenic Res; 2014 Jun; 23(3):441-53. PubMed ID: 24488595
[TBL] [Abstract][Full Text] [Related]
12. Refined human artificial chromosome vectors for gene therapy and animal transgenesis.
Kazuki Y; Hoshiya H; Takiguchi M; Abe S; Iida Y; Osaki M; Katoh M; Hiratsuka M; Shirayoshi Y; Hiramatsu K; Ueno E; Kajitani N; Yoshino T; Kazuki K; Ishihara C; Takehara S; Tsuji S; Ejima F; Toyoda A; Sakaki Y; Larionov V; Kouprina N; Oshimura M
Gene Ther; 2011 Apr; 18(4):384-93. PubMed ID: 21085194
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.
Pienaar IS; Schallert T; Hattingh S; Daniels WM
J Neural Transm (Vienna); 2009 Jul; 116(7):791-806. PubMed ID: 19504041
[TBL] [Abstract][Full Text] [Related]
14. A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene.
Hoshiya H; Kazuki Y; Abe S; Takiguchi M; Kajitani N; Watanabe Y; Yoshino T; Shirayoshi Y; Higaki K; Messina G; Cossu G; Oshimura M
Mol Ther; 2009 Feb; 17(2):309-17. PubMed ID: 19034264
[TBL] [Abstract][Full Text] [Related]
15. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21.
Li CM; Guo M; Salas M; Schupf N; Silverman W; Zigman WB; Husain S; Warburton D; Thaker H; Tycko B
BMC Med Genet; 2006 Mar; 7():24. PubMed ID: 16539728
[TBL] [Abstract][Full Text] [Related]
16. The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer.
Meaburn KJ; Parris CN; Bridger JM
Chromosoma; 2005 Sep; 114(4):263-74. PubMed ID: 16133353
[TBL] [Abstract][Full Text] [Related]
17. A mammalian artificial chromosome engineering system (ACE System) applicable to biopharmaceutical protein production, transgenesis and gene-based cell therapy.
Lindenbaum M; Perkins E; Csonka E; Fleming E; Garcia L; Greene A; Gung L; Hadlaczky G; Lee E; Leung J; MacDonald N; Maxwell A; Mills K; Monteith D; Perez CF; Shellard J; Stewart S; Stodola T; Vandenborre D; Vanderbyl S; Ledebur HC
Nucleic Acids Res; 2004 Dec; 32(21):e172. PubMed ID: 15585659
[TBL] [Abstract][Full Text] [Related]
18. Human chromosome 21q22.2-qter carries a gene(s) responsible for downregulation of mlc2a and PEBP in Down syndrome model mice.
Kazuki Y; Kimura M; Nishigaki R; Kai Y; Abe S; Okita C; Shirayoshi Y; Schulz TC; Tomizuka K; Hanaoka K; Inoue T; Oshimura M
Biochem Biophys Res Commun; 2004 Apr; 317(2):491-9. PubMed ID: 15063784
[TBL] [Abstract][Full Text] [Related]
19. An extra human chromosome 21 reduces mlc-2a expression in chimeric mice and Down syndrome.
Nishigaki R; Shinohara T; Toda T; Omori A; Ichinose S; Itoh M; Shirayoshi Y; Kurimasa A; Oshimura M
Biochem Biophys Res Commun; 2002 Jul; 295(1):112-8. PubMed ID: 12083776
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
